All Posts

written by: Alison Claxton (Clinical Pharmacist) RSV (Respiratory syncytial virus) is a common virus causing respiratory illnesses ranging from mild to severe and life-threatening. Vaccination is recommended for anyone at higher risk of hospitalisation or severe disease. From 15th May 2026, Arexvy RSV vaccine will be free for anyone aged 75 and over, and Aboriginal and Torres Strait Islander people aged 60 and over. Free Arexvy vaccines will be available from all immunisation

written by: Alison Claxton (Clinical Pharmacist) Respiratory syncytial virus (RSV) causes respiratory illnesses ranging from mild to severe. Infections peak in Autumn and Winter. The risk of needing hospitalisation from RSV is highest in babies under 6 months, and older people. It is recommended these groups are immunised against RSV to protect against severe infection. Protection generally lasts for 2 years. The need for further doses has not been established. Different prod

What do the Numbers Tell Us? 🫁 Lung cancer affects many Australians — often without warning. In 2025, around 15,100 Australians are expected to be diagnosed with lung cancer, and nearly 9,000 people are expected to die from it. This makes lung cancer one of the most common cancers and the l eading cause of cancer-related death in Australia. 📊 Across Australia: About 9% of all new cancer diagnoses are lung cancer Around 1 in 21 Australians will be diagnosed with lung canc

☀️ Summer is a wonderful time to enjoy the outdoors, holidays, and community activities. However, the warmer months also bring health risks that can be prevented with a little preparation and awareness. Sun Protection Australia’s UV levels are high, even on cloudy days. Protect your skin by using a broad-spectrum SPF 30+ sunscreen, wearing hats, sunglasses, and protective clothing, and seeking shade during peak UV hours (10am–4pm). Regular skin checks are also important to de